Poster Session C

Poster Session C
Saturday, September 17
4:30 p.m.-7:30 p.m.

In alphabetical order, not board assignment order

• A novel DNA damage detection assay for prediction of individual cancer risk, Wilbur Appledorn, Essen BioScience, Ann Arbor, MI, United States
• A pivotal role for FOXO4 in the regulation of cellular senescence and apoptosis, Peter Barrera, Yale University, New Haven, CT, United States
• Acetaminophen enhances the chemotherapeutic effect of cisplatin and paclitaxel on human ovarian carcinoma cells in vitro, Yingjen Berlin, City of Hope, Duarte, CA, United States
• An oncolytic vaccinia virus encoding the human sodium iodide symporter facilitates long-term deep tissue image monitoring of virotherapy and targeted radiotherapy of pancreatic cancer, Dana Chen, University of Southern California, Los Angeles, CA, United States
• Aspartic acid residues drive the membrane translocation of pHLIP, a therapeutic and imaging agent for solid tumors, Francisco Christopherson, University of Sydney, Sydney, Nsw, Australia
• Asymmetry in chromatin patterns in all cancer daughter cells, Thomas Donndelinger, St. Alphonsus Medical Center, Nampa, ID, United States
• Berberine/cisplatin based radiotherapy for cervical cancer: The new and effective method to treat cervical cancer, Komal Haddad, Memorial Sloan-Kettering Cancer Center, New York, NY, United States
• BMAL1 depletion represses growth of mesothelioma through induction of mitotic catastrophe, Momen Heid, Institute of Radiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
• Cancer cell dependence on unsaturated fatty acids implicates stearoyl-coA desaturase as a target for cancer therapy, Brent Hsiao, University of Iowa, Iowa City, IA, United States
• Catalytic inhibition of human DNA topoisomerase IIα by salicylate and related non-steroidal anti-inflammatory drugs, Ebba Jacobs, Complete Genomics, Mountain View, CA, United States
• Characterization of PinX1 as a coregulator of steroid hormone receptors, Yamilet Kawakami, Chaminade University of Honolulu, Honolulu, Hawaii, United States
• Chemopreventive effects of Brazilian traditional medicine, Tabebuia avellanedae on in vitro and in vivo carcinogetic systems, Harukuni Mi, Georgetown University Medical Center, Washington, DC, United States
• Chromatin remodeling system and visualization of the “archaic” cancer attractors, Yue Mills, University of Oklahoma HSC, Oklahoma City, OK, United States
• Collagen-mediated chromatin remodeling promotes chemo-resistance in pancreatic cancer, Surabhi Trajkovic-Arsic, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
• Complete Genome Sequencing of Complex Tumors and Matched Normals Results in Sensitive Detection of Somatic Events, Sharoni Wang, Geron Corp., Menlo Park, CA, United States
• Dc917 inhibits the growth of mouse lung carcinoma both in vitro and in vivo through cell cycle arrest and ERK signaling pathway, Hang Feitelson, Temple University, Philadelphia, PA, United States
• DMBA-induced skin tumors in HPV16 E7 transgenic mice are affected by Bovine α-Lactalbumin Made Lethal to Tumor Cells (BAMLET)., Provaboti Kagohara, Hospital A.C. Camargo - Pathology Department, Sao Paulo, Sao Paulo, Brazil
• DNA demethylation induces upregulation of telomere repeat-containing RNA (TERRA) and downregulation of telomerase activity in human leukemia cells, Junko Khamas, Department of Surgical Oncology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan
• Docetaxel resistance mechanisms in prostate cancer: p38 MAPK signaling pathway and microtubule dynamics, Weijuan Ohyashiki, Tokyo Medical University, Shinjuku, Tokyo, Japan
• Dysregulation of MicroRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells, Yukihiro Parpart, Georgetown University, Washington, DC, United States
• Endogenous mouse models of pancreatic adenocarcinoma as a preclinical trial platform characterized by multiparametric magnetic resonance imaging, Irina Ramachandran, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States
• Epigenetic regulation of miRNAs and influence on malignancy in Ewing tumors, Guenther Rao, Indiana University, Bloomington, IN, United States
• ErbB-1 and ErbB-2 overexpression in canine mammary cancer and their role as targets in comparative oncology, Marlene Richter, Technische Universitaet Muenchen, Munich, , Germany.
• Extracellular miR-92a secreted by human leukemia cells enhances endothelial cell migration in HUVECs, Tomohiro Sartor, University of Michigan, Ann Arbor, MI, United States
• Ex-vivo cytotoxicity of PNC-27 on primary human ovarian and endometrial cancers, Ehsan Umezu, Tokyo Medical University, Tokyo, Japan
• Gene expression profiling with human breast cancer cell lines exposed to gephyronic acid, Jeanette Zhang, Beth Israel Deaconess Medical Center , Harvard Medical School, Boston, MA, United States
• Heterotetramers of ERBB2 and ERBB3 generate qualitatively distinct signals from heterodimers and provide most of the Neuregulin-induced phosphorylation of ERBB2, Qian Nanyes, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
• High sensitivity of testicular germ cell tumors to PARP inhibitor Olaparib alone and in combination with Cisplatin, Francesca Junco.
• Hypermethylation frequency of CDKN2A and MGMT genes and its association with protein expression levels and clinical and pathologic features in penile carcinomas, Luciane Chun-chieh, Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan
• Identification of epigenetically silenced tumor suppressor genes in colorectal cancer, Ahmed Bargonetti, The City University of New York at Hunter College, New York, NY, United States
• Identification of NAC1 as a novel regulator of autophagy: Its implication in cisplatin resistance, Jin-Ming Barman, UCLA School of Nursing, Los Angeles, CA, United States
• Identification of potential protein targets of isothiocyanates by proteomics, Lixin Cassimeris, Lehigh University, Bethlehem, PA, United States
• IGF-1 signalling enhances mitochondrial activity and biogenesis in cancer cells independently of the glycolytic phenotype, Rosemary Chen, Sanford-Burnham Medical Research Institute at University of California at Santa Barbara, Santa Barbara, CA, United States
• Impacts of ERK signaling on the regulation of antioxidant enzymes and ROS levels in human lung cancer cells exposed to lead acetate, Jia-Ling Chen, Graduate Institue of Medical Sciences, Taipei, Taiwan
• Inhalational chemotherapy for malignant gliomas, Thomas de Keizer, Buck Institute for Research on Aging, Novato, CA, United States
• Inhibition of antiapoptotic BCL2 members facilitates interferon regulatory factor-1 (IRF1) mediated pro-death signaling in breast cancer cells, Jessica Dong, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
• Integrative analysis of pharmacologic, genomic and transcriptomic assays in cancer, Manway Elshazley, Department of Respiratory Medicine, Nagoya Graduate School of Medicine, Nagoya, Japan
• Investigation of a novel molecular descriptor for the lead optimization of 4-aminoquinazolines as vascular endothelial growth factor receptor-2 inhibitors, Joel Komal, All India institute of Medical Sciences, New Delhi, India
• Iron regulatory gene signature predicts outcome in breast cancer, Frank Kurz, University of Calgary, Calgary, Alberta, Canada
• LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types, Maureen Liang, Academia Sinica, Taipei, Taiwan
• Next-generation sequencing reveals CpG island “shore” methylation regulats caveolin-1 expression in breast cancer, Xi Oh, Brain Korea 21 project for Medical Science, Yonsei University College of Medicine, Seoul, Korea (Rep.)
• N-terminal fragment of Bit1 apoptotic protein induces autophagy in tumor cells, Renwei Sarafraz-Yazdi, SUNY Downstate Medical Center, Brooklyn, NY, United States
• Ontogenetic switches in activity and location of multidrug efflux transporters during embryonic development, Amro Schwartz, Georgetown University, Washinton, DC, United States
• Optical imaging of integrin αVβ3 detects pancreatic cancer in endogenous mouse models, Marija Weichselbaumer, Medical University of Vienna, Vienna, Austria
• Over-expression of Brachyury in human carcinoma cells drives the acquisition of resistance to anti-cancer therapeutics, Bruce Wu, Oregon Health and Science University, Portland, OR, United States
• p53 independent 8-amino-adenosine mediated breast cancer cell death, Jill Sun, Tulane Health Sciences Centers, New Orleans, LA, United States
• Phosphorylation of the polycomb group protein polyhomeotic (Ph) induces a relaxed chromatin state through de-polymerization of the Ph SAM domain, David Akao, Gifu University, Gifu, Gifu, Japan
• Potential role of Isorhamnetin to overcome chemoresistance in gastric cancer, Lalitha Cavallo, Università Tor vergata, Rome, Italy
• Quantitative modeling of androgen receptor-mediated transcriptional complexes in human prostate cancer cells, Jordy Dangi-Garimella, Northwestern University, Chicago, IL, United States
• Recombinant viral protein suppresses metastasis of ovarian adenocarcinoma cells through negative Akt signaling, Shu-Mei Huang, Laboratory of Tumor Immunology and Biology, CCR, NCI, NIH, Bethesda, MD, United States
• Role of aneuploidy in cellular adaptation, drug resistance and cancer, Giulia Kong, Cancer Science Institute, Singapore, Singapore
• Selective denuding of nanoparticles for tumor targeting, Jacob Li, UCSF, San Francisco, CA, United States
• Stathmin depletion from cells lacking p53 delays mitotic entry by increasing microtubule stability during interphase, Lynne Noriega, Unam, Mexico, Mexico
• Survival signals differentially turn on during TRAIL or curcumin/TRAIL treatment, Seeun Zhang, University of Miami Miller School of Medicine, Miami, FL, United States
• Targeting the anti-apoptotic protein Mcl-1 in glioblastoma multiforme, Áine Lee, University of California, Davis, Davis, CA, United States
• Telomere length assessment in human archival tumor tissues by quantitative PCR method, Hui O'Connor, University College Cork, Cork, Ireland
• The effects of combined treatment of erlotinib and cisplatin in resistant lung cancer and the role of autophagy in response to chemotherapy, Jasmine Pamarthi, University of Giessen, Giessen, Hessen, Germany
• The epigenomic fingerprint of hepatocellular carcinoma, Sonya Rupnow, Bristol-Myers Squibb, Princeton, NJ, United States
• The identification of cisplatin resistance pathways in lung squamous cell carcinoma and approaches to overcome resistance, Li Ren Yang, Penn State College of Medicine, Hershey, PA, United States
• The myosin II inhibitor, blebbistatin, more potently inhibits 3D cell invasion than 2D cell migration in a human metastatic tumor cell, Daniel Torti, Wake Forest School of Medicine, Winston Salem, NC, United States
• The role of COX-2/PGE2 in gossypol-induced apoptosis of colorectal carcinoma cells, Yen-Chou Yang, Institute of Biotechnology & Department of Life Sciences, National Tsing Hua University, Hsinchu, Taiwan
• The role of prostanoid signaling in lung cancer, Pavan Young, University of Notre Dame, Notre Dame, IN, United States
• Transforming growth factor-beta and vascular endothelial growth factor are enhanced in plasma of breast cancer patients resistent to hormone therapy, Eva Zavadova, Department of Oncology, General Hospital and Medical school, Charles University, Prague, Czech Republic
• Wnt inhibitory factor 1 is silenced by promoter hypermethylation in cervical cancer and its restoration suppresses tumor growth, Ilangovan Hamdoun, UCSD Scripps Institution of Oceanography, La Jolla, CA, United States